May 27, 2024
Last-resort antibiotics such as polymyxin are used for bacterial infections when conventional antibiotics fail. However, new research findings show that bacteria have an innate mechanism that protects them from polymyxin.
Read moreMay 3, 2024
DZL scientists Prof Mareike Lehmann and Prof Miguel Alejandre-Alcazar from Justus Liebig University Giessen have received over half a million euros from the German Research Foundation (DFG) to investigate the link between obesity and lung ageing.
Read moreApril 5, 2024
Climate change, environmental pollution and the decline in biodiversity affect our immune system and increase the risk of immune-mediated diseases such as asthma and allergies.
Read moreMarch 27, 2024
The identification of a new molecule has the potential to open new avenues in the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD).
Read moreFebruary 27, 2024
The wave of protests against right-wing extremism with demonstrations in many places in Germany has been ongoing for about a month. The trigger was revelations by the investigative center Correctiv about a meeting of radical right-wingers in November.
Read moreFebruary 8, 2024
Life-threatening heart and lung diseases, antibiotic resistance in hospital-acquired pathogens, Parkinson's, and coronaviruses - these are the medical challenges that the current research projects of the Von Behring-Röntgen Foundation are addressing.
Read moreJanuary 12, 2024
An international research team, led by lung researchers from Giessen, has discovered a new repair mechanism with therapeutic potential. The work has now been published in "Nature Communications."
Read moreOctober 10, 2023
Lung cancer is considered the most frequently lethal tumor disease in Western countries. The reasons for this are that lung tumors are often only detected in advanced stages and that conventional therapies have limited effectiveness.
Read moreOctober 5, 2023
DZL scientist Prof. Dr. Soni Savai Pullamsetti and her team have discovered signalling pathways involved in developing right heart failure in patients with pulmonary hypertension. The findings, published in the journal Nature, provide new biomarkers for diagnosis and targets for future therapies.
Read moreOctober 4, 2023
Pneumonia, one of the most common causes of death worldwide, is often due to infection with the bacterium Streptococcus pneumoniae.
Read moreSeptember 27, 2023
The National Academy of Sciences Leopoldina is Germany's oldest scientific and medical-learned society. DZL researcher Prof. Pullamsetti was admitted to the prestigious Leopoldina.
Read moreSeptember 25, 2023
As pulmonary hypertension progresses, pathological remodeling processes occur in the right ventricle in response to the increased pressure load.
Read moreSeptember 7, 2023
A new building for the Institute for Lung Health (ILH) is being constructed at the DZL site in Gießen, Marburg, Bad Nauheim.
Read moreAugust 30, 2023
Bei den ERS Awards 2023, die im Rahmen des European Respiratory Society (ERS) International Congress vom 9. -13. September in Mailand verliehen werden, glänzt das DZL mit insgesamt vier beeindruckenden Auszeichnungen.
Read moreAugust 1, 2023
Übergewichtige Menschen mit Asthma unterscheiden sich auf molekularer Ebene von anderen Asthma-Patientinnen und -Patienten. Das hat eine Arbeitsgruppe um DZL-Forscher Prof. Dr. Holger Garn von der Philipps-Universität Marburg herausgefunden.
Read moreJuly 6, 2023
Professor Rajkumar Savai, MD, was awarded the Thoracic Oncology “Mid-Career Achievement Award” for his significant and meaningful contribution to thoracic oncology research at the 2023 Annual Meeting of the American Thoracic Society (ATS) International Conference in Washington, DC, USA.
Read moreJune 21, 2023
Das 11. DZL-Jahrestreffen fand vom 14. bis 16. Juni 2023 in Fürstenfeldbruck statt und war ein voller Erfolg. Über 550 führende Wissenschaftlerinnen und Wissenschaftler der Lungenforschung kamen zusammen, um aktuelle Erkenntnisse und Entwicklungen zu diskutieren.
Read moreJune 12, 2023
Tobacco smoking and air pollution are considered the leading causes of chronic obstructive pulmonary disease (COPD). Despite this, the disease develops in only a few smokers.
Read moreMay 10, 2023
Lungenkrebs ist eine der häufigsten Krebserkrankungen in Deutschland, das nicht-kleinzellige Lungenkarzinom (NSCLC) die häufigste Krebstodesursache. Die sehr schlechte Prognose resultiert aus der oft späten Entdeckung und eingeschränkten Therapieoptionen.
Read moreApril 8, 2023
Der mit 5.000 € dotierte Forschungspreis der gemeinnützigen René Baumgart-Stiftung für wissenschaftliche Arbeiten auf dem Gebiet der pulmonalen Hypertonie wurde im Rahmen des Kongresses der Deutschen Gesellschaft für Pneumologie (DGP) Düsseldorf verliehen.
Read moreMore news can be found on the DZL news site. The link below leads to a pre-filtered overview of all UGMLC-related news.
